FDA Drug Approvals Don't Include Impurities, DC Circ. Rules
The D.C. Circuit affirmed Tuesday the U.S. Food and Drug Administration's win in Sandoz Inc.'s lawsuit challenging the agency's decision to give rival Sanofi exclusivity to its multiple sclerosis drug, Aubagio,...To view the full article, register now.
Already a subscriber? Click here to view full article